SCHEMBL15046451

SCHEMBL15046451

COc1ccc(-c2cn(-c3ccccc3)c(CC(N)=O)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 4/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 1/20 0.50
GABRA2 P47869 1/20 0.50
GABRB2 P47870 1/20 0.50
ALDH1A1 P00352 4/20 0.47
HTT P42858 1/20 0.47
ADORA2A P29274 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
ADORA1 P30542 1/20 0.45
MAPK1 P28482 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A3 P47895 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15033985 0.90 SMN1; SMN2 (0.52) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15046475 0.89 RAB9A (0.51) MEN1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL15046452 0.88 MAPT (0.52) MEN1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL15033984 0.85 GABRA2 (0.58) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15033980 0.80 MAPT (0.52) MEN1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL15046450 0.78 ALDH1A1 (0.55) MEN1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL15046453 0.78 ALDH1A3 (0.49) RAB9ASMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL15034550 0.78 RAB9A (0.54) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15046476 0.78 MAPT (0.52) MEN1RAB9ASMN1; SMN2NPC1LMNA
SCHEMBL15046461 0.77 GABRA2 (0.42) RAB9ASMN1; SMN2LMNAMAPTGABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013087806-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 WO disclosed